Dyne Therapeutics Inc (DYN)
26.02
+0.06
(+0.23%)
USD |
NASDAQ |
May 10, 16:00
26.02
0.00 (0.00%)
After-Hours: 18:59
Dyne Therapeutics Cash from Investing (Quarterly): -179.84M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -179.84M |
December 31, 2023 | 26.20M |
September 30, 2023 | 12.82M |
June 30, 2023 | 17.23M |
March 31, 2023 | 27.06M |
December 31, 2022 | 19.24M |
September 30, 2022 | 51.66M |
June 30, 2022 | 18.44M |
March 31, 2022 | -2.136M |
Date | Value |
---|---|
December 31, 2021 | -0.235M |
September 30, 2021 | -2.848M |
June 30, 2021 | -6.434M |
March 31, 2021 | -128.38M |
December 31, 2020 | -45.22M |
September 30, 2020 | -0.156M |
June 30, 2020 | -0.071M |
March 31, 2020 | -0.211M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-179.84M
Minimum
Mar 2024
51.66M
Maximum
Sep 2022
-11.35M
Average
-0.156M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
Solid Biosciences Inc | 45.30M |
Sana Biotechnology Inc | -77.23M |
Tenaya Therapeutics Inc | -14.92M |
Prime Medicine Inc | 41.28M |
CEL-SCI Corp | -0.0649M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -78.54M |
Cash from Financing (Quarterly) | 408.39M |
Free Cash Flow | -220.48M |
Free Cash Flow Per Share (Quarterly) | -0.9714 |
Free Cash Flow Yield | -12.87% |